European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 55, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:33

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 73, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:31

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 73, Status: Authorised

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Date of authorisation: 13/09/1998, Revision: 52, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:30

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Date of authorisation: 13/09/1998, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:28

Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:14

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:05

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Date of authorisation: 21/03/2014, Revision: 34, Status: Authorised

Submitted by Anonymous (not verified) on 13 October 2026 - 16:03

Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Date of authorisation: 21/03/2014, Revision: 34, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness